164 related articles for article (PubMed ID: 30859397)
1. STAT3 mutations in natural killer cells are associated with cytopenia in patients with chronic lymphoproliferative disorder of natural killer cells.
Kawakami T; Sekiguchi N; Kobayashi J; Yamane T; Nishina S; Sakai H; Hirabayashi Y; Nakazawa H; Ishida F
Int J Hematol; 2019 May; 109(5):563-571. PubMed ID: 30859397
[TBL] [Abstract][Full Text] [Related]
2. A high definition picture of somatic mutations in chronic lymphoproliferative disorder of natural killer cells.
Gasparini VR; Binatti A; Coppe A; Teramo A; Vicenzetto C; Calabretto G; Barilà G; Barizza A; Giussani E; Facco M; Mustjoki S; Semenzato G; Zambello R; Bortoluzzi S
Blood Cancer J; 2020 Apr; 10(4):42. PubMed ID: 32321919
[TBL] [Abstract][Full Text] [Related]
3. STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia.
Jerez A; Clemente MJ; Makishima H; Koskela H; Leblanc F; Peng Ng K; Olson T; Przychodzen B; Afable M; Gomez-Segui I; Guinta K; Durkin L; Hsi ED; McGraw K; Zhang D; Wlodarski MW; Porkka K; Sekeres MA; List A; Mustjoki S; Loughran TP; Maciejewski JP
Blood; 2012 Oct; 120(15):3048-57. PubMed ID: 22859607
[TBL] [Abstract][Full Text] [Related]
4. Linking the KIR phenotype with STAT3 and TET2 mutations to identify chronic lymphoproliferative disorders of NK cells.
Pastoret C; Desmots F; Drillet G; Le Gallou S; Boulland ML; Thannberger A; Doncker AV; Salaun V; Damaj GL; Veyrat-Masson R; Tournilhac O; Moignet A; Pangault C; Roussel M; Fest T; Lamy T
Blood; 2021 Jun; 137(23):3237-3250. PubMed ID: 33512451
[TBL] [Abstract][Full Text] [Related]
5. Chronic lymphoproliferative disorder of NK-cells: A single-institution review with emphasis on relative utility of multimodality diagnostic tools.
Kurt H; Jorgensen JL; Amin HM; Patel KP; Wang SA; Lin P; Kanagal-Shamanna R; Loghavi S; Thakral B; Khogeer HA; Jabbour EJ; Li S; Yin CC; Medeiros LJ; Khoury JD
Eur J Haematol; 2018 May; 100(5):444-454. PubMed ID: 29385279
[TBL] [Abstract][Full Text] [Related]
6. Genomic landscape of T-large granular lymphocyte leukemia and chronic lymphoproliferative disorder of NK cells: a single institution experience.
Fei F; Stehr H; Zehnder JL
Leuk Lymphoma; 2023 Sep; 64(9):1536-1544. PubMed ID: 37330635
[TBL] [Abstract][Full Text] [Related]
7. STAT3 gene mutations and their association with pure red cell aplasia in large granular lymphocyte leukemia.
Ishida F; Matsuda K; Sekiguchi N; Makishima H; Taira C; Momose K; Nishina S; Senoo N; Sakai H; Ito T; Kwong YL
Cancer Sci; 2014 Mar; 105(3):342-6. PubMed ID: 24350896
[TBL] [Abstract][Full Text] [Related]
8.
Muñoz-García N; Jara-Acevedo M; Caldas C; Bárcena P; López A; Puig N; Alcoceba M; Fernández P; Villamor N; Flores-Montero JA; Gómez K; Lemes MA; Hernández JC; Álvarez-Twose I; Guerra JL; González M; Orfao A; Almeida J
Cancers (Basel); 2020 Nov; 12(12):. PubMed ID: 33255665
[No Abstract] [Full Text] [Related]
9. Chronic natural killer lymphoproliferative disorders: characteristics of an international cohort of 70 patients.
Poullot E; Zambello R; Leblanc F; Bareau B; De March E; Roussel M; Boulland ML; Houot R; Renault A; Fest T; Semenzato G; Loughran T; Lamy T
Ann Oncol; 2014 Oct; 25(10):2030-2035. PubMed ID: 25096606
[TBL] [Abstract][Full Text] [Related]
10. T cell large granular lymphocyte leukemia and chronic NK lymphocytosis.
Barilà G; Calabretto G; Teramo A; Vicenzetto C; Gasparini VR; Semenzato G; Zambello R
Best Pract Res Clin Haematol; 2019 Sep; 32(3):207-216. PubMed ID: 31585621
[TBL] [Abstract][Full Text] [Related]
11. Mutations in the signal transducer and activator of transcription family of genes in cancer.
Shahmarvand N; Nagy A; Shahryari J; Ohgami RS
Cancer Sci; 2018 Apr; 109(4):926-933. PubMed ID: 29417693
[TBL] [Abstract][Full Text] [Related]
12. CCL22 mutations drive natural killer cell lymphoproliferative disease by deregulating microenvironmental crosstalk.
Baer C; Kimura S; Rana MS; Kleist AB; Flerlage T; Feith DJ; Chockley P; Walter W; Meggendorfer M; Olson TL; Cheon H; Olson KC; Ratan A; Mueller ML; Foran JM; Janke LJ; Qu C; Porter SN; Pruett-Miller SM; Kalathur RC; Haferlach C; Kern W; Paietta E; Thomas PG; Babu MM; Loughran TP; Iacobucci I; Haferlach T; Mullighan CG
Nat Genet; 2022 May; 54(5):637-648. PubMed ID: 35513723
[TBL] [Abstract][Full Text] [Related]
13. Flow cytometric immunophenotyping is of great value to diagnosis of natural killer cell neoplasms involving bone marrow and peripheral blood.
Jiang NG; Jin YM; Niu Q; Zeng TT; Su J; Zhu HL
Ann Hematol; 2013 Jan; 92(1):89-96. PubMed ID: 22992980
[TBL] [Abstract][Full Text] [Related]
14. Cell size variations of large granular lymphocyte leukemia: Implication of a small cell subtype of granular lymphocyte leukemia with STAT3 mutations.
Tanahashi T; Sekiguchi N; Matsuda K; Takezawa Y; Ito T; Kobayashi H; Ichikawa N; Nishina S; Senoo N; Sakai H; Nakazawa H; Ishida F
Leuk Res; 2016 Jun; 45():8-13. PubMed ID: 27064362
[TBL] [Abstract][Full Text] [Related]
15. Peripheral neuropathy associated with chronic lymphoproliferative disorders of natural killer cells (CLPD-NK): a case report and literature review.
An H; Guo J; Guo H; Hu W; Lu M
BMC Neurol; 2023 Sep; 23(1):314. PubMed ID: 37658347
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic profile of expanded NK cells in chronic lymphoproliferative disorders: a surrogate marker for NK-cell clonality.
Bárcena P; Jara-Acevedo M; Tabernero MD; López A; Sánchez ML; García-Montero AC; Muñoz-García N; Vidriales MB; Paiva A; Lecrevisse Q; Lima M; Langerak AW; Böttcher S; van Dongen JJ; Orfao A; Almeida J
Oncotarget; 2015 Dec; 6(40):42938-51. PubMed ID: 26556869
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary infiltration as the initial manifestation of chronic lymphoproliferative disorder of natural killer cells: a case report and literature review.
Zhang J; Wang P; Yan X
BMC Pulm Med; 2021 Mar; 21(1):94. PubMed ID: 33740949
[TBL] [Abstract][Full Text] [Related]
18. Oral cyclophosphamide was effective for Coombs-negative autoimmune hemolytic anemia in CD16+CD56- chronic lymphoproliferative disorder of NK-cells.
Sekiguchi N; Nishina S; Kawakami T; Sakai H; Senoo N; Senoo Y; Ito T; Saito H; Nakazawa H; Koizumi T; Ishida F
Int J Hematol; 2017 Jun; 105(6):854-858. PubMed ID: 28028749
[TBL] [Abstract][Full Text] [Related]
19. The analysis of clonal diversity and therapy responses using STAT3 mutations as a molecular marker in large granular lymphocytic leukemia.
Rajala HL; Olson T; Clemente MJ; Lagström S; Ellonen P; Lundan T; Hamm DE; Zaman SA; Lopez Marti JM; Andersson EI; Jerez A; Porkka K; Maciejewski JP; Loughran TP; Mustjoki S
Haematologica; 2015 Jan; 100(1):91-9. PubMed ID: 25281507
[TBL] [Abstract][Full Text] [Related]
20. Uncovering the pathogenesis of large granular lymphocytic leukemia-novel STAT3 and STAT5b mutations.
Rajala HL; Porkka K; Maciejewski JP; Loughran TP; Mustjoki S
Ann Med; 2014 May; 46(3):114-22. PubMed ID: 24512550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
